The manuscript," A coronary heart disease prediction model: the Korean Heart Study", by Dr. Sun Ha Jee and colleagues, is an original research paper to construct a coronary heart disease (CHD) risk model among adult 268315 adults (30-74 years old) from the Korean Heart Study (KHS) which was based on multiple health promotion centers, then to compare with The Framingham risk function about the performance measures. After an 11.6-year median follow up and 2722 CHD events, the authors constructed an optimal CHD model, including HDL-C, LDL-C and triglycerides. The authors found the optimal model has a good performance measure, including area under the ROC curve and net reclassification improvement, and the Framingham risk function over-estimated the risk around 3 to 6 folds. Recalibration improved the risk function well. The study is interesting; however, the draft should be criticized on several accounts.
1.
As the title pointed, the authors have constructed a coronary heart disease prediction model; however, readers cannot find any table/sheet/figure in the draft to practically apply in public health and clinical medicine.
2.
Because the data was collected from the second database, as the electronic resource, the quality control and potential diagnosis problem should be mentioned clearly. The relationship between Korean Heart Study (KHS) and National Health Insurance System (NHIS) was unclear from audience; the insurance system has been designed for claims data, not for research purpose. So the potential ascertainment of diagnosis verification is necessary,
3.
The outcome, coronary heart disease, has been defined as "hard" endpoints: for Framingham risk function, hard endpoints were defined as fatal and nonfatal myocardial infarction and cardiac events. In this study, only 73% of myocardial infarction was validated before 2007. The potential misclassification error should be discussed. IN addition, the mentioned sentence about death certificates was unclear in Page 7, Line 21-22.
4.
The authors split the sample into two parts, for test data and validation data, as 1:1 ratio. Maybe 4:1 or bootstrap crossvalidation methods are better than 1:1 method to have an efficient estimator.
5.
The strategy for "comparison of hazard ratios" in Page 8, Line 9 was unclear: why another Cox model is used? The word, "exactly", in Line 15, is confusing.
6.
The method for net reclassification index should be listed in the Results section and potential strength of this method, compared with discrimination statistic, such as area under the ROC curve, should be presented. 8. Table 2 is not useful for constructing the prediction model: first, the categorical grouping of blood pressure and lipids was not augmented in the prediction model. Second, the incidence rates of hard coronary events were not shown.
9.
The estimated coefficients, instead of relative risk values, for constructing the prediction model were used. Table 3 and  Table 4 should provide the estimated coefficients (and standard errors of mean) additionally. IN addition, the authors should provide the reclassification risk category when they calculated the net reclassification index value in Table 3 and  Table 4. 10. In Table 5 , it is better to use estimated coefficients, instead of relative risks, for the model comparison. Also, the authors did not include the status of hypertension medication in the model. 
Confidential Comment to Editor：
The manuscript is designed to provide the prediction model for coronary heart disease among adult Korean population. My concern is that novelty is lacking and methodology is not clearly defined. The most important issue is that I cannot find the constructed model content in the draft.
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GENERAL COMMENTS
This study aimed to develop and improve upon the Framingham CHD Risk Score in a large Korean study of men and women. A few points: As I could not access the referenced methods manuscript (ref 11), I am somewhat unclear about the recruitment and whether participants could be considered as representative of the general population .
Over one third of those enrolled were excluded from this study due to missing data or was this just to incomplete period of follow-up, ? Did you consider multiple imputation for missing data-at least for a sensitivity analysis? You describe collection of data regarding family history under 'methods', but I don't think you mention this again in the manuscript. Some versions of the Framingham score include a multiplier for family history, so I think that at least you should mention your findings in this regard.
In clinical settings classification to high risk groups is used to trigger preventive strategies and you make much of the improvement in classification for men, but it is not clear how you classified risk in the first place (?>10%, ?>20% etc). I'm not sure that the NRI is particularly impressive for either men or women, but plainly in the right direction. Further detail about this would be useful, together with confidence intervals-likewise further detailed description of results for calibration and discrimination (perhaps graphical) would be helpful. Any thoughts about socioeconomic factors? although I know this not a strength of Framingham.
In the appendix we suddenly see equations for stroke risk-is this intended? It seems odd and without any clues as to validity-unless I have missed something. Response: We have provided the algorithm to be used for risk prediction in the appendix. This can be easily programmed into Excel or an app for use by clinicians to apply in practice. We suspect that the reviewer is asking for a "point scoring system", but these are notoriously poor, relative to the complete mathematical formula. In the modern era, when electronic devices for data entry and display of results are virtually universally used, approximate methods are inappropriate, in our view.
2. Because the data was collected from the second database, as the electronic resource, the quality control and potential diagnosis problem should be mentioned clearly. The relationship between Korean Heart Study (KHS) and National Health Insurance System (NHIS) was unclear from audience; the insurance system has been designed for claims data, not for research purpose. So the potential ascertainment of diagnosis verification is necessary.
Response:
The external quality control regarding the measured items was previously reported in our earlier paper as follows:
In 2006 For accuracy of the diagnosis, we have conducted a validation study by checking each medical record following the acquisition of individual consent forms. The AMI records prior to 2007 and after 2008 were found to be as accurate as 73% and 93%, respectively.
Details about this issue have been added in the revised paper on page 7.
3. The outcome, coronary heart disease, has been defined as "hard" endpoints: for Framingham risk function, hard endpoints were defined as fatal and nonfatal myocardial infarction and cardiac events. In this study, only 73% of myocardial infarction was validated before 2007. The potential misclassification error should be discussed. IN addition, the mentioned sentence about death certificates was unclear in Page 7, Line 21-22.
Response: Thank you very much for your comment. We now mention such classification errors in the discussion section. Overall, the number of incident CHD events prior to 2007 was 78(73%) out of 107. The validation study was updated in 2013 with a value of 93%. The validation study on mortality data has not been conducted; therefore, we have added this limitation to the discussion section.
4. The authors split the sample into two parts, for test data and validation data, as 1:1 ratio. Maybe 4:1 or bootstrap cross-validation methods are better than 1:1 method to have an efficient estimator.
Response: There is no right or wrong way to perform data splitting. As the reviewer says, other methods may be better, but we have no way of knowing and there is no theoretical result to provide guidance. Given the size of our sample (and past experience) we would expect the regression coefficients to be consistent across splits. Our method is simple and principled, and we prefer to retain it. 5. The strategy for "comparison of hazard ratios" in Page 8, Line 9 was unclear: why another Cox model is used? The word, "exactly", in Line 15, is confusing.
Response: Thank-you for pointing out the ambiguity in the description. We have now reworded to clarify this matter. (page 8, middle) 6. The method for net reclassification index should be listed in the Results section and potential strength of this method, compared with discrimination statistic, such as area under the ROC curve, should be presented.
Response: A reference to the method is now provided; thank-you for pointing out this omission. NRI is a method for examining reclassification, as the reference explains. It cannot be directly compared to the area under the ROC curve because the latter only measures discrimination. Response: We prefer to retain stratification by sex in table 1, in order to be consistent with our other tables. We have added the additional variables.
8. Table 2 is not useful for constructing the prediction model: first, the categorical grouping of blood pressure and lipids was not augmented in the prediction model. Second, the incidence rates of hard coronary events were not shown.
Response: We did use the groupings in the risk score. The incidence rates are shown in the risk algorithm (page 12), but the incidence rates are now added to Table 2. 9. The estimated coefficients, instead of relative risk values, for constructing the prediction model were used. Table 3 and Table 4 should provide the estimated coefficients (and standard errors of mean) additionally. IN addition, the authors should provide the reclassification risk category when they calculated the net reclassification index value in Table 3 and Table 4 .
Response: In our view, an extended table with estimated coefficients added to the hazard ratios would be unwieldy, and would be most unusual. The hazard ratios are better understood by clinicians and the estimated coefficients (the logs of the hazard ratios) are, in any case, shown in the risk algorithm on page 12).
In revised version, we used the threshold-free version of the NRI. Because CHD is relatively rare in Korea, the usual 10% and 20% 10-year risk thresholds of coronary NRIs are inappropriate for us, whilst no Asian thresholds have yet been established. We apologize for omitting this from the original manuscript. It is now stated.
10. In Table 5 , it is better to use estimated coefficients, instead of relative risks, for the model comparison. Also, the authors did not include the status of hypertension medication in the model.
We did use the estimated coefficients in the model comparison, but this was not made clear. We have revised to clarify this. On the second point, the reviewer seems to be referring to the 2008 publication from Framingham which included hypertension medication as an additional risk factor. However, this paper developed a risk score for CVD. In our paper we produce a Korean risk score for CHD. The latest Framingham risk score for CHD is that of Wilson et al, which is the paper we use as our source for a Framingham score.
11. Some figure, such as Bland-Altman plot, is a better figure in checking reliability and consistency, than Figure 2 which showed the scatter plot of the comparison of KRS and Framingham risk function in both genders.
Response: We agree that the Bland-Altman approach is better for this comparison and have replaced 13. The comment for this study as the first study on Asian population for the Framingham risk function is not true. Many publications have demonstrated that Framingham risk function overestimated the risk of CHD in Asian population, and this study is note the "first" evidence,
